Peggy Scherle

Overview

Peggy Scherle received an average of $2M in total compensation, including $391K in salary, at Prelude Therapeutics from 2020 to 2022.

Source: SEC filings on April 28, 2023 and April 29, 2022.

Related executives

We found five more executives who work or worked at Prelude Therapeutics.

Krishna Vaddi

Prelude Therapeutics

Chief Executive Officer

Jane Huang

Prelude Therapeutics

Chief Medical Officer

Bryant Lim

Prelude Therapeutics

Chief Financial Officer

Brian Piper

Prelude Therapeutics

Chief Financial Officer

Andrew Combs

Prelude Therapeutics

EVP and Head of Chemistry

News

You may also like